Mayne Pharma Group Ltd.ASX: MYX

MYX signs licence agreement for Blissel in Australia

· Issued by Mayne Pharma Group Ltd. via ASX

Filed with ASX · · 2 pages · English

On 6ix: 6ix.com/news/myx-signs-licence-agreement-for-blissel-in-australia

Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call

Release

ASX Announcement MAYNE PHARMA SIGNS EXCLUSIVE LICENCE AGREEMENT FOR BLISSEL® IN AUSTRALIA Key Points • Mayne Pharma has signed an exclusive five-year licence agreement with Italfarmaco S.A for the Australian rights to Blissel®, a menopause hormone therapy (MHT) comprising an...

Mayne Pharma Group Ltd. on 6ix

Story so far

Earlier from Mayne Pharma

Later from Mayne Pharma

All Mayne Pharma news releases